Evidence map›Paper›PMID 36405061›Full record

ReviewChinese herbal medicines2022

Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022.

Kirandeep Kaur, Rashi Sharma, Atamjit Singh, Shivani Attri, Saroj Arora, Sarabjit Kaur, Neena Bedi

Open access · goldAbstract readReview
In one paragraph

Review in Chinese herbal medicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Co-Delivery ofPharmaceutics · 2024
    Article
  9. Pharmacological Significance ofFoods (Basel, Switzerland) · 2024
    Review
  10. Exploring the Pharmacological Potential ofMolecules (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kirandeep KaurDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Rashi SharmaDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Atamjit SinghDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Shivani AttriDepartment of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Saroj AroraDepartment of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Sarabjit KaurDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Neena BediDepartment of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India.
Guru Nanak Dev University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alkannin/shikonin (A/S) and their derivatives are naturally occurring naphthoquinones majorly found in Boraginaceae family plants. They are integral constituents of traditional Chinese medicine Zicao (roots of

Indexed as

alkanninnaphthoquinonespatentsshikonin

Identifiers

PMID36405061
PMCPMC9669360
OpenAlexW4296515637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.